Status:
UNKNOWN
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
Lead Sponsor:
Sun Yat-sen University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
16-65 years
Phase:
PHASE2
Brief Summary
The objective of this study is to evaluate the therapeutic efficacy of allogenic bone marrow stem cells (BMSCs) transplantation in patients with liver cirrhosis. The evaluation of the efficacy include...
Eligibility Criteria
Inclusion
- Aged 16\~65 years.
- Serum HBsAg positive for over six months.
- Ultrasonographic evidences of cirrhosis
Exclusion
- History of moderate to severe hepatic encephalopathy or variceal bleeding during the last two months before enrolment.
- Prothrombin time is over 30s.
- Cirrhosis caused by other reasons except HBV infection.
- Severe problems in other vital organs(e.g.the heart,renal or lungs).
- Liver tumor on ultrasonography, CT or MRI examination.
- Pregnant or lactating women.
- Imaging evidences of vascular thromboses.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01223664
Start Date
October 1 2010
End Date
November 1 2011
Last Update
October 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, Guangdong, China, 510630